Brown Advisory’s Amedisys AMED Stock Holding History

Brown Advisory’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,926	Closed	-$202K	–	1135
2022 Q2	$202K	Sell	1,926 -9	-0.5%	-$1.15K	﹤0.01%	1043
2022 Q1	$333K	Buy	1,935 +9	+0.5%	+$1.34K	﹤0.01%	944
2021 Q4	$312K	Sell	1,926 -5	-0.3%	-$804	﹤0.01%	1021
2021 Q3	$288K	Buy	1,931 +301	+18%	+$62.6K	﹤0.01%	960
2021 Q2	$399K	Sell	1,630 -101	-6%	-$26.5K	﹤0.01%	885
2021 Q1	$458K	Buy	1,731 +106	+7%	+$29.9K	﹤0.01%	864
2020 Q4	$477K	Sell	1,625 -300	-16%	-$76.9K	﹤0.01%	791
2020 Q3	$455K	Hold	1,925	–	–	﹤0.01%	754
2020 Q2	$382K	Hold	1,925	–	–	﹤0.01%	775
2020 Q1	$353K	Hold	1,925	–	–	﹤0.01%	750
2019 Q4	$321K	Hold	1,925	–	–	﹤0.01%	863
2019 Q3	$252K	Sell	1,925 -21	-1%	-$2.73K	﹤0.01%	890
2019 Q2	$236K	Buy	1,946 +21	+1%	+$2.49K	﹤0.01%	939
2019 Q1	$237K	Buy	+1,925	New	+$242K	﹤0.01%	1196

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Brown Advisory's AMED Position: Q3 2022 in Review

Brown Advisory sold out of Amedisys (AMED) in Q3 2022, closing a stake of 1,926 shares — an estimated $202K sold.

Brown Advisory first reported a position in AMED in Q1 2019 and held it in 14 quarters. The position peaked at $477K in Q4 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

Brown Advisory reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
Brown Advisory sold 1,926 Amedisys shares in Q3 2022, an estimated $202K.
Brown Advisory first reported a position in Amedisys in Q1 2019 and held it in 14 quarters.
Brown Advisory's Amedisys position peaked at $477K in Q4 2020.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Brown Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.